the food and drug administration said 0 american home products corp. agreed to recall certain generic drugs that were produced by its quantum pharmics unit in amityville , n.y . quantum stopped shipping the drugs last month , following a federal investigation regarding information 0 the company supplied to obtain three drug approvals . the fda requested the recall of quantum 's mioxidil tablets , chlorazepate dipotassium tablets and meclofenamate sodium capsules because , it said 0 , the size of the production runs submitted for testing to gain fda approval was in each case misrepresented as much larger than it actually was . american home products , based in new york , agreed to recall four other products , trazadone , doxepin , diazepam and lorazapam , because of concerns about data submitted in their original approval applications before the fda . no safety problems with the products are known , the fda said 0 . an fda spokesperson said 0 the drugs are still available under other brand names . last month , american home products said 0 it was suspending production and distribution of all 21 of quantum 's generic drug products pending the completion of an exhaustive internal audit . it also temporarily closed quantum , because of the internal investigation , as well as the fda 's ongoing inquiry . in new york stock exchange composite trading , american home products rose 75 cents to $ 105 on friday .